Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The lack of a fit-for-purpose regulatory framework on nanomedicines and their “generics” poses risks for the safety of EU patients and the European Commission should urgently look to address this, the director of the European Alliance for Access to Safer Medicines (EAASM) has said.
Nanomedicine uses state-of-the-art nanotechnology like nanoparticles, nanorobots or nanoelectronic biosensors for diagnosing or treating diseases.
CONTINUE READING ON www.euractiv.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
